1-46189486-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_017739.4(POMGNT1):​c.1867A>G​(p.Met623Val) variant causes a missense change. The variant allele was found at a frequency of 0.99 in 1,613,718 control chromosomes in the GnomAD database, including 792,524 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M623L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.95 ( 68989 hom., cov: 32)
Exomes 𝑓: 0.99 ( 723535 hom. )

Consequence

POMGNT1
NM_017739.4 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: 5.83

Publications

43 publications found
Variant links:
Genes affected
POMGNT1 (HGNC:19139): (protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)) This gene encodes a type II transmembrane protein that resides in the Golgi apparatus. It participates in O-mannosyl glycosylation and is specific for alpha linked terminal mannose. Mutations in this gene may be associated with muscle-eye-brain disease and several congenital muscular dystrophies. Alternatively spliced transcript variants that encode different protein isoforms have been described. [provided by RefSeq, Feb 2014]
TSPAN1 (HGNC:20657): (tetraspanin 1) The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.4922764E-6).
BP6
Variant 1-46189486-T-C is Benign according to our data. Variant chr1-46189486-T-C is described in ClinVar as Benign. ClinVar VariationId is 167524.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.993 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
POMGNT1NM_017739.4 linkc.1867A>G p.Met623Val missense_variant Exon 21 of 22 ENST00000371984.8 NP_060209.4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
POMGNT1ENST00000371984.8 linkc.1867A>G p.Met623Val missense_variant Exon 21 of 22 1 NM_017739.4 ENSP00000361052.3

Frequencies

GnomAD3 genomes
AF:
0.948
AC:
144297
AN:
152186
Hom.:
68933
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.819
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.982
Gnomad ASJ
AF:
1.00
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
0.999
Gnomad FIN
AF:
1.00
Gnomad MID
AF:
0.981
Gnomad NFE
AF:
0.999
Gnomad OTH
AF:
0.968
GnomAD2 exomes
AF:
0.987
AC:
247112
AN:
250426
AF XY:
0.990
show subpopulations
Gnomad AFR exome
AF:
0.819
Gnomad AMR exome
AF:
0.991
Gnomad ASJ exome
AF:
1.00
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
1.00
Gnomad NFE exome
AF:
1.00
Gnomad OTH exome
AF:
0.993
GnomAD4 exome
AF:
0.995
AC:
1453612
AN:
1461414
Hom.:
723535
Cov.:
113
AF XY:
0.995
AC XY:
723609
AN XY:
726936
show subpopulations
African (AFR)
AF:
0.811
AC:
27156
AN:
33474
American (AMR)
AF:
0.990
AC:
44200
AN:
44644
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
26100
AN:
26106
East Asian (EAS)
AF:
1.00
AC:
39696
AN:
39696
South Asian (SAS)
AF:
1.00
AC:
86085
AN:
86106
European-Finnish (FIN)
AF:
1.00
AC:
53408
AN:
53408
Middle Eastern (MID)
AF:
0.995
AC:
5740
AN:
5768
European-Non Finnish (NFE)
AF:
1.00
AC:
1111582
AN:
1111834
Other (OTH)
AF:
0.988
AC:
59645
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
461
922
1383
1844
2305
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21658
43316
64974
86632
108290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.948
AC:
144413
AN:
152304
Hom.:
68989
Cov.:
32
AF XY:
0.950
AC XY:
70745
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.819
AC:
34025
AN:
41530
American (AMR)
AF:
0.982
AC:
15030
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
3472
AN:
3472
East Asian (EAS)
AF:
1.00
AC:
5186
AN:
5186
South Asian (SAS)
AF:
0.999
AC:
4824
AN:
4828
European-Finnish (FIN)
AF:
1.00
AC:
10626
AN:
10626
Middle Eastern (MID)
AF:
0.983
AC:
289
AN:
294
European-Non Finnish (NFE)
AF:
0.999
AC:
68004
AN:
68042
Other (OTH)
AF:
0.968
AC:
2047
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
329
658
987
1316
1645
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
908
1816
2724
3632
4540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.980
Hom.:
194348
Bravo
AF:
0.941
TwinsUK
AF:
1.00
AC:
3708
ALSPAC
AF:
1.00
AC:
3853
ESP6500AA
AF:
0.828
AC:
3647
ESP6500EA
AF:
0.999
AC:
8595
ExAC
AF:
0.984
AC:
119405
Asia WGS
AF:
0.988
AC:
3437
AN:
3478
EpiCase
AF:
1.00
EpiControl
AF:
0.999

ClinVar

Significance: Benign
Submissions summary: Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 10, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 26, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This is a RefSeq error. The reference base (c.1867A) is the minor allele. This a llele (A) has been identified in 17% (759/4406) of African American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSNP rs6710212) and thus meets criteria to be classified as benign. -

Muscle eye brain disease Benign:2
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 16, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Retinitis pigmentosa 76 Benign:1
Oct 25, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive limb-girdle muscular dystrophy type 2O Benign:1
Oct 25, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3;C3150417:Autosomal recessive limb-girdle muscular dystrophy type 2O Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3 Benign:1
Oct 25, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3 Benign:1
Oct 25, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.044
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.18
CADD
Benign
18
DANN
Benign
0.86
DEOGEN2
Benign
0.18
T;.
Eigen
Benign
-0.67
Eigen_PC
Benign
-0.31
FATHMM_MKL
Benign
0.18
N
LIST_S2
Benign
0.36
T;T
MetaRNN
Benign
0.0000015
T;T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
-0.63
N;N
PhyloP100
5.8
PrimateAI
Uncertain
0.49
T
PROVEAN
Benign
1.3
N;N
REVEL
Uncertain
0.33
Sift
Benign
1.0
T;T
Sift4G
Benign
1.0
T;T
Polyphen
0.0
B;.
Vest4
0.22
MPC
0.25
ClinPred
0.013
T
GERP RS
5.9
Varity_R
0.065
gMVP
0.51
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6659553; hg19: chr1-46655158; COSMIC: COSV100915811; COSMIC: COSV100915811; API